News
Deliberations on IO as first-line therapy for kidney cancer patients
In the point-counterpoint discussion “Immunotherapy for all patients as first line in kidney cancer?” in Plenary Session 04 “Immunotherapy: Evolving paradigms in GU cancers”, Dr. Laurence Albiges (FR) presented her insights in favour of immunotherapy (IO) as first-line treatment....
Video: Update on EAU Prostate Cancer Center consensus meeting
Prof. Dr. Peter Albers (DE) on the importance of specialised prostate cancer centres and where we are at this moment.
Video: Prostate cancer management: Implementation without good evidence?
Prof. James N’Dow talks about the most pressing evidence gaps in treating patients with prostate cancer and which technological advances will help to improve PCa management.
The future of good evidence gathering for PCa
New approaches to clinical trials can lead to more successful results in the challenging near future. Parallel, comparative studies and a better selection of patients are just some positive developments in the generation of useful evidence for prostate cancer...
PCa management essentials opens EMUC’s 10th year
Throughout a decade, the European Multidisciplinary Congress on Urological Cancers (EMUC) has established its reputation as the leading platform where multidisciplinary specialists with expertise in urological malignancies come together. This year, EMUC commences in Amsterdam, The Netherlands. The programme...
ESUP Symposium: a multidisciplinary look at the future of bladder cancer treatment
A multidisciplinary team of speakers discussed bladder cancer at the ESUP Symposium on Thursday. The Symposium was jointly organized by the EAU Section of Urological Research (ESUR) and the European Society of Pathology Uropathology Working Group (ESUP). It took...
Birtle to present key POUT findings and updates at EMUC18
The PeriOperative chemotheraphy or sUrveillance in upper Tract urothelial cancer, also known as POUT (CRUK/11/027; NCT01993979, NIHR portfolio) is the largest clinical trial in upper tract urothelial cancer (UTUC) with findings supporting the use of adjuvant platinum based chemotherapy...
EMUC18: Everything in prostate cancer pathology you were afraid to ask
Marking its 10th year, this year’s annual European Multidisciplinary Congress on Urological Cancers (EMUC18) will emphasise the synergies from multidisciplinary teamwork (MDT) to highlight that comprehensive cancer care is only possible when various experts work together to identify and...
EMUC18: Joint initiatives reinforce effective MDT in onco-urology
Multidisciplinary teamwork, although a widely-accepted practice in medicine, still has a long way to go in actual clinical and research work considering new challenges encountered by physicians such as the introduction of new diagnostic and treatment agents and their...
EMUC18: Costs and optimal PCa care- Finding the crucial balance
Across Europe the debate has begun on how to deliver uniform and quality care for prostate cancer (PCa) patients in the region, but healthcare experts and physicians are encountering deeply-rooted issues that range from financial costs, poor patient recruitment...